PTCT - PTC Therapeutics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts15151516
Avg. Estimate-1.56-1.03-4.18-3
Low estimate-3.04-1.52-5.97-7.5
High estimate-0.58-0.28-2.36-1.14
Year ago EPS-2.13-1.53-7.79-4.18
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts13131616
Avg. Estimate206.84M220.26M961.48M961.17M
Low estimate182.89M200.21M912.68M818.03M
High estimate238.1M267.11M1.01B1.15B
Year ago sales165.53M186.9M698.8M961.48M
Sales growth (year/est)25.00%17.80%37.60%-0.00%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-1.33-1.24-1.59-1.52
Actual EPS-2.13-1.53-2.35-1.88
Difference-0.8-0.29-0.76-0.36
Surprise %-60.20%-23.40%-47.80%-23.70%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-1.56-1.03-4.18-3
7 days ago-1.56-1.04-4.18-3
30 days ago-1.62-1.26-4.73-3.79
60 days ago-1.59-1.3-4.48-4.02
90 days ago-1.58-1.27-4.45-3.95
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 days1111
Up last 30 days7111110
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesPTCTIndustrySector(s)S&P 500
Current qtr.26.80%N/AN/AN/A
Next qtr.32.70%N/AN/AN/A
Current year46.30%N/AN/AN/A
Next year28.20%N/AN/AN/A
Next 5 years (per annum)-9.51%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A